• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Technology Events 2025-2026
  • Sponsored Post
    • Make a Contribution
  • Technology Jobs
  • Technology Markets
  • About
    • GDPR
  • Contact

Genomic Vision Announces a Strategic Partnership With GIPTIS (Genetics Institute for Patients, Therapies, Innovation & Science) Focusing on the Fight Against Genetic Diseases

January 15, 2020 By admin Leave a Comment

GENOMIC VISION (Paris:GV) (FR0011799907 – GV), a biotechnology company developing Molecular and Artificial Intelligence tools to investigate DNA structural and dynamic changes, in particular in the human genome, is pleased to announce a partnership with GIPTIS, the future Euro Mediterranean Institute founded by Professor Nicolas Lévy, head of the Medical Genetic Department at the renowned hospital of “La Timone” in Marseille. The aim of this partnership is to accelerate and facilitate the diagnosis and treatment of patients, thanks to Genomic Vision proprietary technology and expertise.

In order to improve the management of patients affected by rare genetic diseases, GIPTIS has defined as main objectives to accelerate diagnosis, increase research capacity, multiply the number of effective treatments and improve the care of patients and families.

Professor Nicolas Lévy explains: “Genomic Vision has developed a powerful technology that helps to understand complex genetic abnormalities, in particular in aging and neurological diseases, two therapeutic areas with high unmet clinical needs. It is really helpful in particular to characterize genomic regions with highly repeated sequences for which NGS technologies are not efficient enough.”

Terms of the partnership include several research programs with the development of news assays targeting specific genetic disorders on which Genomic Vision will have exclusive commercialization rights.

Aaron Bensimon, CEO and co-founder of Genomic Vision, adds: “It is the fusion between technological innovation and unmet clinical needs that will cross the frontiers and will bring to the doctors and patients novel tests. Genomic Vision and GIPTIS are the appropriate partners to develop such a novel approach. GIPTIS will bring to GV an important source of unmet medical need in the field of neurological diseases and will be a major asset for the development and validation of these new tests. We are very proud to have been selected by this prestigious institute to participate in this outstanding project. It is not only an opportunity to set-up new IVD assays, but also an opening to Southern markets in which genetic disease rates are higher than elsewhere.”

ABOUT GIPTIS
Today, rare genetic diseases affect 3 million people in France, more than cancer and Alzheimer’s disease combined, and 50 million around the Mediterranean. More than 95% of patients are without adequate treatment and 60% of them are children.

In the majority of cases, these diseases are serious, disabling, chronic and have an impact on entire families.

The aim of GIPTIS: to treat patients better, faster and on a larger scale by facilitating collaborations between the best of the public and private sectors, academic and industrial worlds. GIPTIS unites medical teams, fundamental and applied research teams, start-ups, drug companies and patients associations in the same innovative place of excellence.

GIPTIS faces 4 challenges: accelerate the diagnoses, increase research capacity, multiply the number of effective treatments, improve care for patients and families.

Founded by internationally acclaimed geneticist, Professor Nicolas Lévy, GIPTIS will be a non-profit foundation with mixed governance, for successful cooperation between private and public sectors.

ABOUT GENOMIC VISION
GENOMIC VISION is a biotechnology company developing molecular assays and Artificial Intelligence tools to control quality and safety of genetically modified genomes, in particular in genome editing technologies and biomanufacturing processes. These tools are currently use for monitoring DNA replication in cancerous cell, for early cancer detection and the diagnosis of genetic diseases. Based near Paris, in Bagneux, the Company has approximately 30 employees. GENOMIC VISION is a public listed company listed in compartment C of Euronext’s regulated market in Paris (Euronext: GV – ISIN: FR0011799907).

For further information, please visit www.genomicvision.com.

Membre des indices CAC® Mid & Small et CAC® All-Tradable

Filed Under: Tech Tagged With: genome editing technologies

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • Unify Raises $40M to Redefine Go-To-Market with AI Agents That Scale Sales
  • Seagate Unleashes 30TB Hard Drives to Fuel AI Infrastructure at the Edge
  • Firefly Takes Flight: Adobe’s Mobile Expansion Sparks New Growth Horizon
  • SkyDrive’s ¥8.3 Billion Pre-Series D Raise Anchors Japan’s Air Mobility Future
  • HPE and Juniper: A Strategic Fusion at the Core of AI-Native Networking
  • Adobe Inc. Analysis Report: Navigating Uncertainty with Resilience
  • NOS: A New Reactor for American Nuclear Ambition
  • Adobe Introduces LLM Optimizer to Help Brands Navigate the Generative AI Shift
  • Why Visa and Mastercard Stocks Slipped After the Stablecoin News
  • iOS 26: The Most Personal, Intelligent, and Private iPhone Experience Yet

Media Partners

  • Market Analysis
  • Cybersecurity Market
EU Blinks First: Temporary Suspension of Tariff Countermeasures Signals Strategic Caution in U.S. Trade Conflict
AMD Set to Surge: $250 Target Within Reach as AI Momentum Accelerates
China’s Strategic Shift to RISC-V: Market Implications and Growth Prospects
Understanding Transfer Pricing: A Key Component of Multinational Business Operations
A Comprehensive Tour of Project Management Tools and Integration Platforms
Implementing Odoo ERP in a Small Manufacturing Enterprise: Costs and Considerations
Economic Optimism Meets Uncertainty: Blue Chip Indicators Highlight Post-Election Fiscal Concerns and AI’s Looming Impact
The Future of Connectivity: Insights from Ericsson’s November 2024 Mobility Report
Platinum Market Faces Sustained Deficit Amidst Strong Demand and Constrained Supply
Breaking Beijing’s Grip: U.S. and Australia Unite Against China’s Rare Earth Monopoly
SquareX Collaborates with Top Fortune 500 CISOs to Launch The Browser Security Field Manual at Black Hat
CrowdStrike Deepens AWS Partnership to Drive Secure AI Adoption and Innovation
CyberArk Expands Identity Security with Secure Cloud Access and Agent Guard in AWS Marketplace AI Category
CyberBay2025: Forging the Future of Digital Defense, October 13–15 2025, Tampa Marriott Water Street
GitGuardian Launches MCP Server to Bring Secrets Security into Developer Workflows
Stellar Cyber 6.0.0: Ushering in the Human-Augmented Autonomous SOC
MITRE Unveils AADAPT Framework to Safeguard Digital Financial Systems
Cogent Security Emerges from Stealth to Tackle the Fastest-Growing Threat in Cybersecurity with AI-Powered Vulnerability Management
Cyber’s Leading Minds Take the Stage at Black Hat USA 2025
INE Security Launches Enhanced eMAPT Certification

Media Partners

  • Market Research Media
  • Technology Conferences
Adobe Set to Hit $640: AI Growth and Financial Strength Signal Imminent Breakout
The Rise of Headless Content Frameworks in Distributed Media Projects
Developing Web Projects: From Concept to Launch
The Rise of APS-C Cameras: A Professional Renaissance in Photography
Market Brief: Disruption in Spanish Orange Supply Chain and Strategic Response by UK Retailers
Global AI-Powered Movie Scenario Market Analysis 2023-2030: Growth, Trends, and Forecast
Market Research Report: US Government Cybersecurity Market in 2024
Market Research Report: Global Advertising Revenue Projections and Trends in the Entertainment & Media Industry
Social Media: The Rise of Formulaic Content
Netflix’s Creative Decline: The Rise of Formulaic Content
Apple Announces WWDC25, June 9 to 13, 2025
Adobe Summit 2025, March 17-20, Las Vegas
Embedded World 2025, from 11 to 13 March 2025 in Nuremberg
SATELLITE 2025: Uniting the Global Satellite and Space Communities
The milestone 10th edition of Chatbot Summit on March 31 – April 1, 2025, The Ritz-Carlton, Berlin
Snowflake Summit 2025, scheduled for June 2-5, 2025, in San Francisco
The NVIDIA GPU Technology Conference (GTC) 2025 is set to take place from March 17 to 21 at the San Jose McEnery Convention Center in San Jose, California
The Taipei Nangang Exhibition Center is set to host COMPUTEX 2025 from May 20 to May 23
The Mobile World Congress (MWC 2025) will kick off from March 3 to 6 in Barcelona, Spain
IOT Solutions World Congress 2025: Forging the Future of Industrial Innovation

Copyright © 2022 Technologies.org

Media Partners: Market Analysis & Market Research and Exclusive Domains